Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-08-09

FDA Approved: TAYTULLA — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved a supplemental application for TAYTULLA (norethindrone acetate and ethinyl estradiol, and ferrous fumarate), updating its labeling and authorizatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TAYTULLA (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, AND FERROUS FUMARATE)

Snippet

SUPPL AP for TAYTULLA (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, AND FERROUS FUMARATE)